Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
New insights into monoclonal B-cell lymphocytosis.
Biomed Res Int. 2014;2014:258917. doi: 10.1155/2014/258917. Epub 2014 Sep 11.
Biomed Res Int. 2014.
PMID: 25295254
Free PMC article.
Review.
Clinical aspects of malt lymphomas.
Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Kyriakaki S, Yiakoumis X, Sachanas S, Moschogiannis M, Tsirkinidis P, Korkolopoulou P, Papadaki HA, Angelopoulou MK.
Kalpadakis C, et al. Among authors: kyriakaki s.
Curr Hematol Malig Rep. 2014 Sep;9(3):262-72. doi: 10.1007/s11899-014-0218-1.
Curr Hematol Malig Rep. 2014.
PMID: 25240474
Review.
Item in Clipboard
Serum Levels of Soluble FLT3 Ligand in Patients with Active Multiple Myeloma Constitute Marker of Bone Marrow Plasma Cell Proliferative Activity.
Kokonozaki M, Kanellou P, Pappa CA, Vyzoukaki R, Sarantoulaki S, Stavroulaki E, Kyriakaki S, Alegakis A, Boula A, Alexandrakis MG.
Kokonozaki M, et al. Among authors: kyriakaki s.
Crit Rev Oncog. 2017;22(3-4):255-262. doi: 10.1615/CritRevOncog.2018021355.
Crit Rev Oncog. 2017.
PMID: 29604902
Item in Clipboard
Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.
Kokonozaki M, Tsirakis G, Devetzoglou M, Kyriakaki S, Antonakis A, Vyzoukaki R, Pappa CA, Tzardi M, Alexandrakis MG.
Kokonozaki M, et al. Among authors: kyriakaki s.
Leuk Res. 2015 Dec;39(12):1467-72. doi: 10.1016/j.leukres.2015.10.009. Epub 2015 Oct 20.
Leuk Res. 2015.
PMID: 26521986
Item in Clipboard
The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.
Tsirakis G, Pappa CA, Kaparou M, Boula A, Katsomitrou V, Xekalou A, Kyriakaki S, Alexandrakis MG.
Tsirakis G, et al. Among authors: kyriakaki s.
Tumour Biol. 2013 Apr;34(2):859-64. doi: 10.1007/s13277-012-0618-6. Epub 2012 Dec 16.
Tumour Biol. 2013.
PMID: 23242610
Item in Clipboard
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma.
Tsirakis G, Roussou P, Pappa CA, Kolovou A, Vasilokonstantaki C, Miminas I, Kyriakaki S, Alegakis A, Alexandrakis MG.
Tsirakis G, et al. Among authors: kyriakaki s.
Med Oncol. 2014 Jan;31(1):778. doi: 10.1007/s12032-013-0778-2. Epub 2013 Nov 26.
Med Oncol. 2014.
PMID: 24277416
Item in Clipboard
Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma.
Alexandrakis MG, Pappa CA, Kolovou A, Kyriakaki S, Vyzoukaki R, Devetzoglou M, Tsirakis G.
Alexandrakis MG, et al. Among authors: kyriakaki s.
Med Oncol. 2014 May;31(5):953. doi: 10.1007/s12032-014-0953-0. Epub 2014 Apr 13.
Med Oncol. 2014.
PMID: 24729186
Item in Clipboard
Cite
Cite